Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer

British Journal of Cancer

Volumn 75, Issue 2, 1997, Pages 202-207

  Korbelik, M ^a,c   Naraparaju, V R ^b   Yamamoto, N ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b ALBERT EINSTEIN CANCER CENTER   (United States)

^c BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

Binding protein derived macrophage activating factor; Immunosuppression; Macrophage activating factor; Mouse SCCVII tumour; Photodynamic therapy; Photofrin; Tumour cure

Indexed keywords

MACROPHAGE ACTIVATING FACTOR; PHOTOFRIN; VITAMIN D BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER MODEL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0031026520     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.34     Document Type: Article

References (27)

1. Cho Y-H, Straight RC and Smith JH (1992) Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model. J Urol 147: 743-746
2. Cooke NE and Haddad JG (1986) Vitman D binding protein (Gc-globulin). Endocrine Rev 10: 294-307
3. Elmets CA and Bowen KD (1986) Immunological suppression in mico treated with hematoporphyrin derivative photoradiation. Cancer Res 46: 1608-1611
4. Evans S, Matthews W, Perry R, Fraker D, Norton J and Pass HI (1990) Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl Cancer Inst 82: 34-34
5. Fisher AMR, Murphree AL and Gomer CJ (1995) Clinical and preclinical photodynamic therapy. Lasers Surg Med 17: 2-31
6. α-binding protein-derived macrophage activating factor on Ehrlich tumor bearing mice, 87th Ann Am Assoc Cancer Res Proc 37: 481
7. Korbelik M (1996) Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg 17: 329-334
8. Korbelik M and Krosl G (1994) Enhanced macrophage cytotoxicity against tumor cells treated with photodynamic therapy. Photochem Photobiol 60: 497-302
9. Korbelik M and Krosl G (1996) Photosensitizer distribution and photosensitized damage of tumor tissues. In The Fundamental Bases of Phototherapy, Hönigsmann H, Jori G and Young AR (eds), pp. 229-245. OEMF spa: Milan
10. Korbelik M, Krosl G, Naraparaju VR and Yamamoto N (1995) The effect of enzymatically generated macrophage activating factor (GcMAF) on the tumor response to photodynamic therapy. Photochem Photobiol 61: 97S
11. Korbelik M, Krosl G, Krosl J and Dougherty GJ (1996) Modulation of tumor response to photodynamic therapy in severe combined immunodeficient (SCID) mice by adoptively transferred lymphoid cells. SPIE 2675: 156-162
12. Krosl G and Korbelik M (1994) Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). Cancer Lett 84: 43-49
13. Krosl G, Korbelik M and Dougherly GJ (1995) Induction of immune cell infiltration into murine SCCVII tumour by Photofrin-based photodynamic therapy. Br J Cancer 71: 549-555
14. Krosl G, Korbelik M, Krosl J and Dougherty GJ (1996) Potentiation of photodynamic therapy elicited antitumor response by localized treatment with granulocyte-macrophage colony stimulating factor. Cancer Res 56: 3281-3286
15. α-Sepharose chromatography. Anal Biochem 157: 262-269
16. Lynch DH, Haddad S, Vernon KJ, OTT MJ, Straight RC and Jolles CJ (1989) Systemic immunnsuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages. Photochem Photobiol 49: 453-458
17. Myers RC, LAU BUS, Kunihira DY, Torrey RR, Woolley JL and Tosk J (1989) Modulation of hematoporphyrin derivative-sensitized phototherapy with Corynebacterium parvum in murine transitional cell carcinoma. Urology 33: 230-235
18. Naraparaju VR and Yamamoto N (1994) Roles of β-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages. Immunol Lett 43: 143-148
19. α-binding protein-derived macrophage activating factor. 87th Ann Am Assoc Cancer Res Proc 37: 213
20. Suit HD, Sedlacek, RS, Silver G and Dosoretz D (1985) Pentobarbital anesthesia and the response of tumor and normal tissue in the C3Hf/Sed mouse to radiation. Radiat Res 104: 47-65
21. α binding protein (group-specific component) is a precursor for the macrophage actuating signal factor front lysophospahtidylcholine-treated lymphocyles. Proc Natl Acad Sci USA 88: 8539-8543
22. α-binding protein in activation of macrophages. J Immunol 157: 1744-1751
23. Yamamoto N and Naraparaju VR (1996b) A defect in inducible β-galactosidase of B lymphocytes in the osteopetrotic (mi-my) mouse. Immunology 88: 605-611
24. Yamamoto N, St Claire DA, Homma S and Ngwenya BZ (1988) Actuation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. Cancer Res 48: 6044-6049
25. Yamamoto N, Homma S, Sery TW, Donoso LA and Hoober KJ (1991) Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of peritoneal cells with haematoporphyrin derivative and light. Eur J Cancer 27: 467-471
26. Yamamoto N, Hoober K, Yamamoto N and Yamamoto S (1992) Tumoricidal capacities of macrophages photodynamically activated with hematoporphyrin derivative. Photochem Photobiol 56: 245-250
27. Yamamoto N, Lindsay DD, Naraparaju VR, Ireland RA and Popoff SN (1994) A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats. J Immunol 152: 5100-5107